Table 3.

Characteristics of patients whose antiglaucoma ophthalmic solution use did not change during the study period (numbers in parentheses are standard deviation).

Group	Patients, n	Age, years mean (SD)	Type of glaucomaa (POAG:NTG:OH)	Male, %	# of antiglaucoma ophthalmic solution	Initial BCVAb	Final BCVA	Initial MDc (dB)	Final MD (dB)
IA (Internet Access)	46	63.7 (12.8)	21:24:1	66.7	1.5 (0.9)	0.08 (0.38)	0.10 (0.40)	–6.01 (7.32)	–7.04 (7.61)
NIA (Non−Internet Access)	55	66.4 (10.7)	21:32:2	61.1	1.2 (0.8)	0.09 (0.31)	0.10 (0.25)	–6.67 (7.24)	–8.07 (7.94)

^aPOAG: primary open angle glaucoma, NTG: normal tension glaucoma, OH: ocular hypertension.

^bBCVA: best-corrected visual acuity.

^cMD: mean deviation.